Pharma Pushing Virus Theory for "Blood Pressure Vaccine"

A new study suggesting that a common virus might play a role in hypertension has some suggesting that a vaccine might be developed against high blood pressure.


http://www.naturalnews.com/027059_blood_high_blood_pressure_blood_vessels.html


A number of companies, including GlaxoSmithKline, Novartis, Sanofi-Aventis and Vical are already at work on a CMV vaccine. While the virus rarely produces symptoms in healthy adults, it can cause harm to people with compromised immune systems and can produce birth defects in infants exposed prenatally.

CHICK-CHING goes the cash register!

Tweet